Submitted by Anonymous (not verified) on 13 September 2024 - 15:49
Orphan designation: camrelizumab Treatment of hepatocellular carcinoma, 25/07/2024 Positive
Source:
Orphan designation: camrelizumab Treatment of hepatocellular carcinoma, 25/07/2024 Positive